UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence

Cancers, 2024-08, Vol.16 (15), p.2706

2024

Volltextzugriff (PDF)

Prostate-specific antigen (PSA) bounce following salvage radiotherapy to the prostate bed in a patient with prostate cancer post-prostatectomy

International cancer conference journal, 2020-10, Vol.9 (4), p.217-220

2020

Volltextzugriff (PDF)

‘Godrevy Project’: virtual reality for symptom control and well-being in oncology and palliative care – a non-randomised pre-post interventional trial

BMJ Oncology, 2023-12, Vol.2 (1), p.e000160

2023

Volltextzugriff (PDF)

Significance of Anemia in Outcomes After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Clinical colorectal cancer, 2017-12, Vol.16 (4), p.381-385

2017

Volltextzugriff (PDF)

Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?

Cancer medicine (Malden, MA), 2024-06, Vol.13 (12), p.n/a

2024

Volltextzugriff (PDF)

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

The New England journal of medicine, 2019-12, Vol.381 (25), p.2391-2402

2019

Volltextzugriff (PDF)

A UK real-world observational study of avelumab + axitinib (A + Ax) in advanced renal cell carcinoma (aRCC): 24-month interim results

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.631-631

2023

Volltextzugriff (PDF)

The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.81-81

2020

Volltextzugriff (PDF)

Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective

British journal of cancer, 2024-04, Vol.130 (6), p.897-907

2024

Volltextzugriff (PDF)

A UK real-world observational study of avelumab + axitinib (A + Ax) in advanced renal cell carcinoma (aRCC): Outcomes at 36 months post treatment initiation

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.386-386

2024

Volltextzugriff (PDF)

The emerging use of immunotherapy as a treatment option in metastatic renal cell carcinoma: Real-world evidence from a single UK tertiary cancer centre

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16509-e16509

2023

Volltextzugriff (PDF)

The impact of socioeconomic deprivation on mortality in cervical cancer patients in Cornwall (England)

European journal of cancer care, 2021-09, Vol.30 (5), p.e13463-n/a

2021

Volltextzugriff (PDF)

EP336/#1095 Developing a central database and virtual biobank for rare gynaecological cancers in the UK: rango (rare neoplasms of gynaecological origin)

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A191-A191

2022

Volltextzugriff (PDF)

A multicenter real-world study reviewing systemic anticancer treatment choices and drop off rates between treatment lines for metastatic renal cell carcinoma in the United Kingdom: In the immunotherapy era

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.358-358

2022

Volltextzugriff (PDF)

Obesity and visceral fat: Survival impact in high-grade endometrial cancer

European journal of obstetrics & gynecology and reproductive biology, 2021-01, Vol.256, p.425-432

2021

Volltextzugriff (PDF)

The RAINBO MMRd-GREEN trial (GCIG/DGOG/ENGOT-EN14 2 ): A phase III trial on the addition of adjuvant durvalumab to radiotherapy in patients with high-risk MMRd endometrial cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5633-TPS5633

2023

Volltextzugriff (PDF)

Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.689-689

2023

Volltextzugriff (PDF)

The role of sarcopenic obesity in high‐grade endometrial cancer

International journal of gynecology and obstetrics, 2021-08, Vol.154 (2), p.248-255

2021

Volltextzugriff (PDF)

Reducing delays in the diagnosis and treatment of muscle-invasive bladder cancer using simulation modelling

Journal of clinical urology, 2019-03, Vol.12 (2), p.129-133

2019

Volltextzugriff (PDF)

Characterization of Microplastics in the Water Column of Western Lake Superior

Fox, John McGrane

2021

Volltextzugriff (PDF)

An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks

Journal of clinical urology, 2022-05, Vol.15 (3), p.257-263

2022

Volltextzugriff (PDF)

2022-RA-1505-ESGO Ovarian cancer retrospective European (O’CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A344-A344

2022

Volltextzugriff (PDF)

The Significance of Anaemia in Outcomes After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Clinical colorectal cancer, 2017

2017

Volltextzugriff (PDF)

Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study

International journal of radiation oncology, biology, physics, 2021-07, Vol.110 (4), p.1143-1150

2021

Volltextzugriff (PDF)

Real World Patterns of PSA Response and Survival with Abiraterone and Enzalutamide in Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Clinical Oncology and Research, 2020-07, p.1-6

2020

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence

Prostate-specific antigen (PSA) bounce following salvage radiotherapy to the prostate bed in a patient with prostate cancer post-prostatectomy

‘Godrevy Project’: virtual reality for symptom control and well-being in oncology and palliative care – a non-randomised pre-post interventional trial

Significance of Anemia in Outcomes After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

A UK real-world observational study of avelumab + axitinib (A + Ax) in advanced renal cell carcinoma (aRCC): 24-month interim results

The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer

Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective

A UK real-world observational study of avelumab + axitinib (A + Ax) in advanced renal cell carcinoma (aRCC): Outcomes at 36 months post treatment initiation

The emerging use of immunotherapy as a treatment option in metastatic renal cell carcinoma: Real-world evidence from a single UK tertiary cancer centre

The impact of socioeconomic deprivation on mortality in cervical cancer patients in Cornwall (England)

EP336/#1095 Developing a central database and virtual biobank for rare gynaecological cancers in the UK: rango (rare neoplasms of gynaecological origin)

A multicenter real-world study reviewing systemic anticancer treatment choices and drop off rates between treatment lines for metastatic renal cell carcinoma in the United Kingdom: In the immunotherapy era

Obesity and visceral fat: Survival impact in high-grade endometrial cancer

The RAINBO MMRd-GREEN trial (GCIG/DGOG/ENGOT-EN14 2 ): A phase III trial on the addition of adjuvant durvalumab to radiotherapy in patients with high-risk MMRd endometrial cancer

Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021

The role of sarcopenic obesity in high‐grade endometrial cancer

Reducing delays in the diagnosis and treatment of muscle-invasive bladder cancer using simulation modelling

Characterization of Microplastics in the Water Column of Western Lake Superior

An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks

2022-RA-1505-ESGO Ovarian cancer retrospective European (O’CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression

The Significance of Anaemia in Outcomes After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study

Real World Patterns of PSA Response and Survival with Abiraterone and Enzalutamide in Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Suchergebnisse filtern